Ness Technologies to be acquired by affiliate of CVCI

The affiliate of Citi Venture Capital International (CVCI) will do the acquisition in a deal valued at around USD 307 million

PTI | June 13, 2011



Ness Technologies, Inc., a global provider of information technology solutions and services, announced today that the company has entered into a merger agreement under which an affiliate of Citi Venture Capital International (CVCI), a global private equity investment fund, will acquire it in a deal valued at around USD 307 million.

Under the terms of the agreement, Ness stockholders will receive USD 7.75 per share in cash for each share of common stock they hold, representing a premium of 17.6 per cent over the closing price of the company?s shares on the Nasdaq Global Select Market on Jun 9, 2011, the last trading day prior to today?s announcement, a company statement said.

Alternatively, it could also mean a premium of 22.2 per cent over the average closing price of the company?s shares over the 30 trading days prior to Jun 10, 2011, the company said.

?We believe this transaction provides attractive value for our stockholders and represents an exciting opportunity for Ness, our over-500 customers and our 6,900 employees to continue our growth and development in partnership with CVCI,? said Sachi Gerlitz, president and CEO, Ness Technologies.

?We look forward to completing the transaction and continuing to provide superior solutions and services to our strong customer base, as we build upon our leadership position in our markets and continue to implement our strategic plan", he said.
 

Comments

 

Other News

How the mind can help the body heal itself

Why do some people recover from illness against all odds? Can our beliefs, emotions and consciousness influence the body’s ability to heal? Drawing on over three decades of experience in medicine, research and medical innovation, internationally trained ophthalmologist and author Dr Dinesh Verma ex

1,364 anti-cancer formulations to cost less from today

The National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, has capped trade margins on the Maximum Retail Price (MRP) of 137 anti-cancer drugs. This was based on the recommendations of an Expert Committee constitute

Who checks the books?

I read about the news about the Coimbatore library over coffee this morning. On the face of it, the headline was about a political ‘war’ between the DMK and TVK. But what stayed with me was something much more important than the blame game behind what had transpired. A writer walking through

Development paradox: Falling poverty miracle and an inequality problem

India’s reduction in poverty over the past decade is a development achievement of considerable significance. The World Bank’s April 2026 ‘India Development Update’ estimates that the share of Indians living below the international extreme-poverty line of $3.00 per person per day i

In Arunachal, a river we call mother

In Arunachal Pradesh, the Siang is not just a river. For many of us, especially the Adi people, it is part of our family. Our grandparents fished in it. Children learned to swim in it. Our farms drink from it. When someone says a huge dam will be built on it, we do not hear the word "project".

A new retelling of the Mahabharata delves into key moments

In a time when every decision carries consequences and questions of ambition, power, loyalty, identity and moral choice continue to shape our lives, Dr. Arun Krishnan’s new book, ‘Mahakshana’ (Penguin India) offers a strikingly relevant retelling of the Mahabharata.  

Upcoming Conferences



-->

Archives

Current Issue

Opinion

Facebook Twitter Google Plus Linkedin Subscribe Newsletter

Twitter